
Health
retatrutide is a chemical compound and experimental weight-loss drug that targets three appetite-related hormones.

Lilly’s experimental drug compared with Ozempic in the diabetes study.
1 min

Retatrutide is an experimental weekly injectable obesity drug developed by Eli Lilly. It is designed to mimic three hormones: GLP-1, GIP and glucagon.
4 min